The most important thing to keep in mind when you look at Walgreens today is -- unfortunately-- its weak business performance ...

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. While there's a potential turnaround opportunity for the business in the years ahead, that ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement rates for prescription drugs.

Walgreens Boots Alliance (WBA) closed at $11.16 in the latest trading session, marking a +0.95% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.58%.

The firm set a “hold” rating on the pharmacy operator’s stock. Several other brokerages have also issued reports on WBA. Truist Financial cut their target price on Walgreens Boots Alliance […] ...

Walgreens Boots Alliance's fiscal third-quarter results came in above FactSet consensus estimates. Total revenue of $39 billion was up 7.2% year over year, and adjusted earnings per share declined ...

The firm owned 4,401 shares of the pharmacy operator’s stock after selling 2,844 shares during the period. CVA Family Office LLC’s holdings in Walgreens Boots Alliance were worth $49,000 as of ...

Detailed price information for Walgreens Boots Alliance (WBA-Q) from The Globe and Mail including charting and trades.

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.